Matches in Wikidata for { <http://www.wikidata.org/entity/Q64725234> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q64725234 description "assaig clínic" @default.
- Q64725234 description "clinical trial" @default.
- Q64725234 description "clinical trial" @default.
- Q64725234 description "clinical trial" @default.
- Q64725234 description "clinical trial" @default.
- Q64725234 description "ensaio clínico" @default.
- Q64725234 description "ensayo clínico" @default.
- Q64725234 description "ensayu clínicu" @default.
- Q64725234 description "essai clinique" @default.
- Q64725234 description "klinisch onderzoek" @default.
- Q64725234 description "клінічне випробування" @default.
- Q64725234 name "Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes" @default.
- Q64725234 type Item @default.
- Q64725234 label "Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes" @default.
- Q64725234 prefLabel "Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes" @default.
- Q64725234 P1050 Q64725234-D8387FDE-EE02-4865-95EF-A9FE8F4649C4 @default.
- Q64725234 P1132 Q64725234-CB93CD98-AEDF-4098-90A7-77F56ACE5064 @default.
- Q64725234 P131 Q64725234-CC804A93-BD63-4AFA-91DB-F1A26DEEA32B @default.
- Q64725234 P1476 Q64725234-412EE285-5D46-49EC-A178-E74C84EA30D6 @default.
- Q64725234 P17 Q64725234-0C65B2FE-B3E3-49BA-BFF1-B8F7C791A7D5 @default.
- Q64725234 P17 Q64725234-6D6CCD92-14A0-4032-AE9E-69504B3F065E @default.
- Q64725234 P17 Q64725234-B4A54979-8884-4C40-8277-CE5836B7F129 @default.
- Q64725234 P17 Q64725234-C10ADE54-8BBE-4351-B64B-706E25C0D281 @default.
- Q64725234 P17 Q64725234-CBCE620D-451D-4C30-86A8-433A5A074274 @default.
- Q64725234 P17 Q64725234-E61FD1D8-6B55-4B44-9DA8-85E2731AFA4F @default.
- Q64725234 P2899 Q64725234-30642F53-FD26-42CC-A7FD-7E1B41E18651 @default.
- Q64725234 P3098 Q64725234-78D302B8-78BB-4C9B-BE7F-EAEFB9E6E53A @default.
- Q64725234 P31 Q64725234-6C801422-D6C2-4073-8456-20F789C26468 @default.
- Q64725234 P4844 Q64725234-4AEA7051-678D-4474-A191-35BD4983BF2F @default.
- Q64725234 P580 Q64725234-FB3B8554-D451-4D72-99AF-C8081398D274 @default.
- Q64725234 P582 Q64725234-ACBEB26B-4F57-44D3-9066-05AFA934B2FB @default.
- Q64725234 P6099 Q64725234-09DD2CC9-3DF2-4906-821E-18944D49B852 @default.
- Q64725234 P6153 Q64725234-BE35DAAA-C7F2-4D54-A43F-E9949211C597 @default.
- Q64725234 P8363 Q64725234-2331AAF1-9C2E-40F8-95DF-6DEE108D95E3 @default.
- Q64725234 P1050 Q12206 @default.
- Q64725234 P1132 "+193" @default.
- Q64725234 P131 Q8646 @default.
- Q64725234 P1476 "Efficacy and Safety of Initiation of Biphasic Insulin Aspart 30 Treatment in Subjects With Type 2 Diabetes Mellitus Failing OAD Therapy" @default.
- Q64725234 P17 Q334 @default.
- Q64725234 P17 Q408 @default.
- Q64725234 P17 Q833 @default.
- Q64725234 P17 Q865 @default.
- Q64725234 P17 Q869 @default.
- Q64725234 P17 Q928 @default.
- Q64725234 P2899 "+18" @default.
- Q64725234 P3098 "NCT00605111" @default.
- Q64725234 P31 Q30612 @default.
- Q64725234 P4844 Q1929845 @default.
- Q64725234 P580 "2003-12-01T00:00:00Z" @default.
- Q64725234 P582 "2004-10-01T00:00:00Z" @default.
- Q64725234 P6099 Q42825046 @default.
- Q64725234 P6153 Q818846 @default.
- Q64725234 P8363 Q78089383 @default.